Shariah compliance overview
HalalStarling Oncology, Inc. (STLN) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Starling Oncology, Inc.
Starling Oncology, Inc., formerly The Oncology Institute, is a value-based oncology company advancing cancer care in the community setting. Founded in 2007, the company offers cutting-edge, evidence-based cancer treatments, including clinical trials and transfusions, to a large patient population.
Starling Oncology, Inc. (STLN) operates in the Healthcare sector, in the Medical - Care Facilities industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 0.00% (limit 5%), interest-bearing debt is 13.22% (limit 30%) and interest-bearing securities and assets are 5.73% (limit 30%).
- Business Activity
- 0.00%Limit 5%Pass
- Interest-bearing debt
- 13.22%Limit 30%Pass
- Interest-bearing securities and assets
- 5.73%Limit 30%Pass
- Dividend purification
- 0.00%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Starling Oncology, Inc. (STLN). Current Akinda screening label: Halal.
